Literature DB >> 21514234

Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study.

Timothy H Holtz1, Gaëtan Kabera, Thuli Mthiyane, Tainos Zingoni, Sidhambaram Nadesan, Douglas Ross, Jennifer Allen, Sekai Chideya, Henry Sunpath, Roxana Rustomjee.   

Abstract

BACKGROUND: In 2007, WHO released revised recommendations and an algorithm for the diagnosis and treatment of smear-negative pulmonary tuberculosis in seriously ill people living with HIV/AIDS. We aimed to assess the effect of the recommendations on clinical outcome in patients in South Africa.
METHODS: We enrolled seriously ill patients (aged ≥15 years) with HIV infection and suspected smear-negative pulmonary tuberculosis from three hospitals in KwaZulu-Natal, South Africa. Patients were consecutively enrolled into two cohorts: the first cohort was managed according to standard practice, and the second according to the WHO-recommended algorithm. The primary endpoints were rates of continued stay in hospital at 7 days after admission and survival at 8 weeks after admission.
FINDINGS: 338 patients were enrolled in the standard practice cohort between August, 2008, and February, 2009, and 187 were enrolled in the algorithm cohort between March, 2009, and December, 2009. 7 days after hospital admission, 27% (n=50) of patients in the algorithm cohort were still in hospital, compared with 38% (n=130) in the standard practice cohort (rate ratio 0·70, 95% CI 0·53-0·91; p=0·009). 8 weeks after admission, 83% (n=156) of patients in the algorithm cohort were alive, compared with 68% (n=230) in the standard practice cohort (1·23, 1·11-1·35; p=0·0001), with effect modified by hospital location.
INTERPRETATION: In seriously ill patients with HIV infection and suspected smear-negative pulmonary tuberculosis, early antituberculosis treatment according to the WHO algorithm could significantly reduce mortality in South Africa. FUNDING: US President's Emergency Plan for AIDS Relief.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514234     DOI: 10.1016/S1473-3099(11)70057-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  27 in total

1.  Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.

Authors:  Winceslaus Katagira; Nicholas D Walter; Saskia Den Boon; Nelson Kalema; Irene Ayakaka; Eric Vittinghoff; William Worodria; Adithya Cattamanchi; Laurence Huang; John Lucian Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

2.  Optimal treatment of Codisease due to HIV and tuberculosis.

Authors:  C Fordham von Reyn
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

3.  Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.

Authors:  Jonathan G Peter; Grant Theron; Richard van Zyl-Smit; Asheen Haripersad; Lynelle Mottay; Sarah Kraus; Anke Binder; Richard Meldau; Anneli Hardy; Keertan Dheda
Journal:  Eur Respir J       Date:  2012-02-23       Impact factor: 16.671

4.  Optimizing Tuberculosis Diagnosis in Human Immunodeficiency Virus-Infected Inpatients Meeting the Criteria of Seriously Ill in the World Health Organization Algorithm.

Authors:  Rulan Griesel; Annemie Stewart; Helen van der Plas; Welile Sikhondze; Molebogeng X Rangaka; Mark P Nicol; Andre P Kengne; Marc Mendelson; Gary Maartens
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

Review 5.  Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Graeme Meintjes; Haileyesus Getahun; Diane V Havlir; Robin Wood
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

6.  The sixth vital sign: HIV status assessment and severe illness triage in Uganda.

Authors:  M J Cummings; E Goldberg; S Mwaka; O Kabajaasi; E Vittinghoff; A Katamba; A Cattamanchi; N Kenya-Mugisha; J L Davis; S T Jacob
Journal:  Public Health Action       Date:  2017-11-13

7.  Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosis.

Authors:  Thuli Mthiyane; Jonny Peter; Jenny Allen; Cathy Connolly; Malika Davids; Roxana Rustomjee; Timothy H Holtz; Lesibana Malinga; Keertan Dheda
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 8.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

9.  Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.

Authors:  Christina Yoon; Adithya Cattamanchi; J Lucian Davis; William Worodria; Saskia den Boon; Nelson Kalema; Winceslaus Katagira; Sylvia Kaswabuli; Cecily Miller; Alfred Andama; Heidi Albert; Pamela Nabeta; Christen Gray; Irene Ayakaka; Laurence Huang
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

10.  Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?

Authors:  Jonathan G Peter; Grant Theron; Keertan Dheda
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.